WHO ICTRP trial
Lutein and zeaxanthin supplementation in preterm infants to prevent retinopathy…
ISRCTN10624844 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN10624844 |
|---|---|
| Public title | Lutein and zeaxanthin supplementation in preterm infants to prevent retinopathy of prematurity |
| Scientific title | LUtein and zeaxanthin SUpplementation in Preterm infants to prevent RetinOpathy of Prematurity: a multicentre prospective randomised double-blind placebo-controlled study |
| Primary sponsor | University of Florence (Italy) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Italy |
| Conditions | Retinopathy of prematurity (ROP) Eye Diseases Retinopathy of prematurity |
| Interventions | Infants at each unit were grouped in blocks: 1. 1st block: gestational age < 25+6 weeks 2. 2nd block: gestational age from 26+0 to 28+6 weeks 3. 3rd block: gestational age > 29+0 weeks) Infants were randomly assigned to a treatment group… |
| Registration date | Jun 15, 2011 |
| Target size | 242 |
| Secondary IDs | 01/2008 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: